Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection
Launched by BIRMINGHAM WOMEN'S NHS FOUNDATION TRUST · Nov 30, 2007
Trial Information
Current as of June 04, 2025
Terminated
Keywords
ClinConnect Summary
· What we do not know: Treatment of hydrosalpinx and IVF Several studies in the literature have suggested that the treatment of hydrosalpinx pre-IVF would improve the pregnancy rate to a level similar to tubal disease patients without hydrosalpinx. The treatment modalities explored were salpingectomy, salpingostomy, tubal occlusion and ultrasound-guided aspiration either one month before or at the time of egg collection. All studies reported to date have been retrospective and with poor control design. A prospective randomised controlled trial is needed. All modalities have been associated ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • healthy women, ASA class 1 (normal healthy) or class 2 (with mild systemic disease);
- • undergoing IVF or ICSI and reaching the stage of egg collection;
- • with ultrasonically diagnosed hydrosalpinx and identifiable during the phase of ovarian stimulation;
- • giving written informed consent.
- Exclusion Criteria:
- • patients not giving written informed consent;
- • patients cancelled for poor ovarian response;
- • ultrasonically diagnosed hydrosalpinx and identifiable for the first time at egg-collection
About Birmingham Women's Nhs Foundation Trust
Birmingham Women's NHS Foundation Trust is a leading healthcare organization dedicated to providing high-quality women's and neonatal services. Committed to advancing clinical research, the Trust plays a pivotal role in conducting innovative clinical trials that aim to improve health outcomes for women and their families. With a multidisciplinary approach, the Trust collaborates with various stakeholders to ensure rigorous scientific standards and ethical practices are upheld in all research initiatives. Its focus on patient-centered care and commitment to excellence positions Birmingham Women's NHS Foundation Trust as a key contributor to advancements in women's health and medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, , United Kingdom
Patients applied
Trial Officials
Nahed Hammadieh, MD,MRCOG
Principal Investigator
Assisted Conception Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials